202 related articles for article (PubMed ID: 32093988)
1. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
Li L; Han Z; Li L; Han L; Yan B
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
Cui M; Huang CY; Wang F
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
[TBL] [Abstract][Full Text] [Related]
4. Paroxetine use in medically ill patients.
Stout SS; Somerset WI; Miller A; Musselman DL
Psychopharmacol Bull; 2003; 37 Suppl 1():108-22. PubMed ID: 14566206
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of paroxetine in the treatment of poststroke depression.
Ma C; Li P
Medicine (Baltimore); 2018 Jul; 97(29):e11496. PubMed ID: 30024530
[TBL] [Abstract][Full Text] [Related]
6. [Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
Horváth S; Karányi Z; Harcos P; Nagy Z; Németh G; Andor G
Orv Hetil; 2006 Dec; 147(50):2397-404. PubMed ID: 17274185
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
8. A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
Mazeh D; Shahal B; Aviv A; Zemishlani H; Barak Y
Int Clin Psychopharmacol; 2007 Nov; 22(6):371-5. PubMed ID: 17917556
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine for the treatment of depression: a critical update.
Gibiino S; Serretti A
Expert Opin Pharmacother; 2012 Feb; 13(3):421-31. PubMed ID: 22263916
[TBL] [Abstract][Full Text] [Related]
10. [Paroxetine (paxil): use in clinical practice].
Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
[No Abstract] [Full Text] [Related]
11. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial.
Paile-Hyvärinen M; Wahlbeck K; Eriksson JG
BMC Fam Pract; 2003 May; 4():7. PubMed ID: 12747810
[TBL] [Abstract][Full Text] [Related]
13. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
Paolucci S; Antonucci G; Grasso MG; Morelli D; Troisi E; Coiro P; De Angelis D; Rizzi F; Bragoni M
Cerebrovasc Dis; 2001; 12(3):264-71. PubMed ID: 11641594
[TBL] [Abstract][Full Text] [Related]
14. Focus on paroxetine.
Green B
Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
16. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?
Komaroff AL
Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725
[No Abstract] [Full Text] [Related]
17. Comparative efficacies of fluoxetine and paroxetine in major depression across varying acute-phase treatment periods: a meta-analysis.
Wang Y; Yu L; Xie J; Chen J; Wei Q
Asia Pac Psychiatry; 2014 Dec; 6(4):353-62. PubMed ID: 24150924
[TBL] [Abstract][Full Text] [Related]
18. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
19. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S
Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608
[TBL] [Abstract][Full Text] [Related]
20. [Increased perioperative blood loss during treatment with paroxetine].
Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
